Related Experiment Video
Updated: Jun 27, 2026

08:00
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
ExonMiner: Web service for analysis of GeneChip Exon array data
Kazuyuki Numata1, Ryo Yoshida, Masao Nagasaki
1Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan. numata@ims.u-tokyo.ac.jp
BMC Bioinformatics
|November 28, 2008
Summary
ExonMiner is a web service for analyzing exon array data to identify disease-specific splice variations. This tool aids in discovering potential biomarkers for diseases like cancer by analyzing large transcript datasets.
Area of Science:
- Genomics
- Bioinformatics
- Molecular Biology
Background:
- Splicing isoform-specific transcriptional regulations are linked to diseases.
- Detecting splice variations is crucial for understanding disease-specific transcriptional regulation.
- Affymetrix Human Exon 1.0 ST Array provides exon-level expression data for genome-wide analysis.
Purpose of the Study:
- To develop a comprehensive web service for analyzing exon array data.
- To detect transcripts with significantly different splicing patterns between cell types (e.g., normal vs. cancer).
- To identify exon-level biomarkers for diseases.
Main Methods:
- Developed ExonMiner, an all-in-one web service for exon array data analysis.
- Implemented data normalization, two-way ANOVA statistical analysis, and visualization (heatmaps, barplots).
- Utilized a supercomputer system for genome-wide analysis of over 300,000 transcripts.
Main Results:
- ExonMiner successfully identifies transcripts with significantly different splice patterns.
- The service enables efficient visualization and meta-analysis for biomarker detection.
- Genome-wide analysis revealed potential aberrant splice variations in cancer cells.
Conclusions:
- ExonMiner is a user-friendly, web-based tool requiring only internet browser access.
- It allows for rapid analysis of large exon array datasets within hours.
- The platform provides high-level statistical analysis to identify aberrant splice variants as biomarkers.

